Telomerase: A potential molecular marker and therapeutic target for cancer

Journal of Surgical Oncology

Volumn 87, Issue 1, 2004, Pages 1-3

  Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 6; MOLECULAR MARKER; PROTEIN BAX; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELL KILLING; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; DNA STRAND BREAKAGE; EDITORIAL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; IMMUNE RESPONSE; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; RNA DEGRADATION;

CELL CYCLE; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 3042736699     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20076     Document Type: Editorial

References (17)

1. Yu H-P, Xu S-Q, Lu W-H, et al.: Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus. J Surg Oncol 2004;86:99-104.
2. Morales CP, Gandia KG, Ramirez RD, et al.: Characterisation of telomerase immortalized normal human oesophageal squamous cells. Gut 2003;52:327-333.
3. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene 2002;21:643-649.
4. Herbert BS, Pitts AE, Baker SI, et al.: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999;96:14276-14281.
5. Lin T, Gu J, Zhang L, et al.: Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effect on primary human hepatocytes. Cancer Res 2002;62:3620-3625.
6. Lin T, Huang X, Gu J, et al.: Longterm tumor free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene 2002;21:8020-8028.
7. Gu J, Kagawa S, Takakura M, et al.: Tumor-specific transgene expression form the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res 2001;60:5359-5364.
8. Gu J, Andreff M, Roth JA, et al.: hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gene Ther 2002;9:30-37.
9. Koga S, Hirohata S, Kondo Y, et al.: A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Hum Gene Ther 2000;11:1397-1406.
10. Komato T, Kondo Y, Kanzawa T, et al.: Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res 2001;61:5796-5802.
11. Jacob D, David J, Zhu H, et al.: Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Clin Cancer Res 2004;10:3535-3541.
12. Huang Q, Zhang X, Wang H, et al.: A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin Cancer Res 2004;10:1439-1445.
13. Nair SK, Heiser A, Boczkowski D, et al.: Induction of cytotoxic T lymphocyte responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000;6:1011-1017.
14. Vonderheide RH, Schultze JL, Anderson KS, et al.: Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res 2001;61:8366-8370.
15. Vonderheide RH: Telomerase as a universal tumor-associated antigen for cancer immunotherapy. Oncogene 2002;21:674-679.
16. Minev B, Hipp J, Firat H, et al.: Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci USA 2000;97:4796-4801.
17. Herbert BS, Wright AC, Passons CM, et al.: Inhibition of the spontaneous immortalization of breast epithelial cells from individuals predisposed to breast cancers: Effects of chemopreventive and anti-telomerase agents. J Natl Cancer Inst 2001;93:39-45.